In News Flash
New Guacher Treatment Produced in Israel
The FDA has approved a clinical trial for a new treatment method for Gaucher Disease, a hereditary disease that affects 10,000 people worldwide. Protalix BioTherapeutics, an Israeli company in Carmiel, developed a cheaper enzyme replacement therapy than already exists. One in fifteen Ashkenazi Jews carry the Gaucher gene.